Clinical Trials Logo

Clinical Trial Summary

Er:YAG ablative fractional laser-assisted methyl aminolevulinate photodynamic therapy (AFL-PDT) has shown significantly higher efficacy and a lower recurrence rate at 12 months than methyl aminolevulinate photodynamic therapy (MAL-PDT) for treatment of Bowen's disease (BD). However, long-term follow up data are not available.


Clinical Trial Description

To compare the long-term efficacy and recurrence rates of AFL-PDT and standard MAL-PDT for the treatment of lower extremity BD. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03320447
Study type Interventional
Source Dong-A University
Contact
Status Completed
Phase Phase 1
Start date October 30, 2011
Completion date October 19, 2017

See also
  Status Clinical Trial Phase
Completed NCT03012009 - Laser Assisted Drug Delivery in the Treatment of Superficial Non Melanoma Skin Cancer: a Randomized Controlled Trial N/A
Completed NCT02085395 - Clinical Study Assessment of SR-T100 Topical Gel Against Actinic Keratosis Phase 2
Recruiting NCT03909646 - Surgical Excision Versus Photodynamic Therapy and Topical 5-fluorouracil in Treatment of Bowen's Disease Phase 4
Terminated NCT00472706 - Trial of Excision Versus Photodynamic Therapy in the Treatment of Bowen's Disease Phase 4
Completed NCT04293679 - Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With isSCC Phase 1/Phase 2
Completed NCT01912976 - Study of Methyl Aminolaevulinate Photodynamic Therapy With and Without Er:YAG Laser in Bowen's Disease Phase 1
Active, not recruiting NCT06014697 - OCT and Invasion in Cutaneous Skin Lesions
Completed NCT03167762 - Photographing the Skin During Photodynamic Therapy N/A
Recruiting NCT02759900 - Using a Cold Atmospheric Plasma Device to Treat Skin Disorders N/A
Recruiting NCT05402046 - Clinical vAlidation of a MobilE appLication ("ProRodinki") in the Assessment of the maLignant skIn neoplAsms N/A
No longer available NCT00535080 - Compassionate Use of Metvix® (Methyl Aminolevulinate) Photodynamic Therapy (PDT) in Subjects With Field Actinic Keratoses, Large/Multiple Superficial Basal Cell Carcinomas (BCCs), or Bowen's Disease